The affinity of bopindolol and its two metabolites for a beta 2-adrenoceptor in the bovine mesenteric artery
- PMID: 7841957
- DOI: 10.1248/bpb.17.1296
The affinity of bopindolol and its two metabolites for a beta 2-adrenoceptor in the bovine mesenteric artery
Abstract
Bopindolol and its two metabolites (18-502 and 20-785) were examined for their affinity to a beta 2-adrenoceptor in the bovine mesenteric artery using the radioligand binding assay method with [3H]CGP12177 as a radioligand. The Scatchard analysis of the data demonstrated a uniphasic plot with Kd and Bmax values of 0.86 +/- 0.16 nM, and 13.34 +/- 1.11 fmol/mg protein, respectively. The pKi values of bopindolol and its two metabolites for beta 2-adrenoceptors in the bovine mesenteric artery were 7.70 +/- 0.13, 8.07 +/- 0.13, 8.20 +/- 0.24, respectively, with 20-785 showing the highest values among these drugs. The present findings indicate that the bovine mesenteric artery membrane is predominantly beta 2-adrenoceptor tissue, and that bopindolol and its two metabolites were potent for beta 2-adrenoceptors in the bovine mesenteric artery.
Similar articles
-
Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).Biol Pharm Bull. 1996 Jul;19(7):932-5. doi: 10.1248/bpb.19.932. Biol Pharm Bull. 1996. PMID: 8839963
-
Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.J Pharmacobiodyn. 1991 May;14(5):250-5. doi: 10.1248/bpb1978.14.250. J Pharmacobiodyn. 1991. PMID: 1685186
-
Assessment of affinities of propranolol and bopindolol to membranes from COS-7 cell transiently transfected with beta-1- and beta-2-adrenoceptors using a radioligand-binding assay method.Pharmacology. 2000 Jul;61(1):6-10. doi: 10.1159/000028373. Pharmacology. 2000. PMID: 10895074
-
Bopindolol: pharmacological basis and clinical implications.Cardiovasc Drug Rev. 2001 Spring;19(1):9-24. doi: 10.1111/j.1527-3466.2001.tb00180.x. Cardiovasc Drug Rev. 2001. PMID: 11314603 Review.
-
Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.Drugs. 1991 Jan;41(1):130-49. doi: 10.2165/00003495-199141010-00010. Drugs. 1991. PMID: 1706984 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources